» Authors » Jowita Fraczkiewicz

Jowita Fraczkiewicz

Explore the profile of Jowita Fraczkiewicz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 137
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Liszka K, Marschollek P, Przystupski D, Fraczkiewicz J, Mielcarek-Siedziuk M, Olejnik I, et al.
J Fungi (Basel) . 2025 Jan; 11(1). PMID: 39852457
Introduction: Posaconazole is recommended for prophylaxis in pediatric immunocompromised patients. Due to its variability in bioavailability and drug-to-drug interactions, EBMT recommends regimens based on therapeutic drug monitoring (TDM). Materials And...
2.
Styczynski J, Czyzewski K, Demidowicz E, Wozniak M, Plonowski M, Sawicka-Zukowska M, et al.
Leuk Lymphoma . 2024 Oct; 66(2):333-336. PMID: 39412390
No abstract available.
3.
Sekowska A, Czyzewski K, Jaremek K, Zalas-Wiecek P, Zajac-Spychala O, Wachowiak J, et al.
J Clin Med . 2024 Jul; 13(14). PMID: 39064118
is a nosocomial pathogen that causes severe infections in immunocompromised patients. The aim of the study was to conduct a microbiological and clinical analysis of infections in children with malignancies...
4.
Marschollek P, Liszka K, Mielcarek-Siedziuk M, Dachowska-Kalwak I, Haze N, Panasiuk A, et al.
Biomedicines . 2024 Jul; 12(7). PMID: 39062195
CD19-targeted CAR-T cell therapy has revolutionized the treatment of relapsed/refractory (r/r) pre-B acute lymphoblastic leukemia (ALL). However, it can be associated with acute toxicities related to immune activation, particularly cytokine...
5.
Fraczkiewicz J, Pawinska-Wasikowska K, Szymbor K, Balwierz W, Skoczen S, Czyzewski K, et al.
J Clin Med . 2024 Apr; 13(7). PMID: 38610794
Patients treated with hemato-oncological malignancies (HO) or undergoing cellular therapies such as hematopoietic stem cell transplantation (HSCT) or chimeric antigen receptor T cells (CAR-T) were significantly affected by severe acute...
6.
Lyzwa M, Kedziora K, Kalamarz N, Fraczkiewicz J, Panasiuk A, Owoc-Lempach J, et al.
Cent Eur J Immunol . 2024 Apr; 48(4):350-357. PMID: 38558560
Activated phosphoinositide 3-kinase syndrome (APDS) is a recently described disease characterized by recurrent infections, lymphoproliferation with a high risk of malignancy, early-onset cytopenia, and a propensity for autoimmune diseases. Hematopoietic...
7.
Zawitkowska J, Drabko K, Lejman M, Kowalczyk A, Czyzewski K, Dziedzic M, et al.
Sci Rep . 2023 Dec; 13(1):22619. PMID: 38114744
The most common complications related to the treatment of childhood acute lymphoblastic leukemia (ALL) are infections. The aim of the study was to analyze the incidence and mortality rates among...
8.
Masetti R, Leardini D, Muratore E, Fabbrini M, DAmico F, Zama D, et al.
Blood . 2023 Oct; 142(16):1387-1398. PMID: 37856089
The correlation existing between gut microbiota diversity and survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) has so far been studied in adults. Pediatric studies question whether this association applies...
9.
Marschollek P, Liszka K, Mielcarek-Siedziuk M, Rybka B, Ryczan-Krawczyk R, Panasiuk A, et al.
Biomedicines . 2022 Nov; 10(11). PMID: 36428483
The optimal bridging therapy before CAR-T cell infusion in pediatric relapsed or refractory B-cell precursor acute lymphoblastic leukemia (r/r BCP-ALL) still remains an open question. The administration of blinatumomab prior...
10.
Szmit Z, Fraczkiewicz J, Salamonowicz-Bodzioch M, Krol A, Ussowicz M, Mielcarek-Siedziuk M, et al.
J Clin Med . 2022 Sep; 11(17). PMID: 36079123
Hematopoietic stem cell transplantation (HSCT) is a curative therapy for an increasing number of nonmalignant indications. Its use is restricted by severe transplant-related complications, including CMV infection; despite various prophylactic...